Hereditary Hepatorenal Tyrosinemia Natural History in Egypt and the Arab World (Multicenter Clinical Study)
Launched by YASSIN ABDELGHAFFAR CHARITY CENTER FOR LIVER DISEASE AND RESEARCH · Feb 19, 2018
Trial Information
Current as of June 04, 2025
Unknown status
Keywords
ClinConnect Summary
The purpose of this study is to create an electronic registry of phenotypic, laboratory information, treatment and outcomes options for tyrosinemia type I. The registry is longitudinal in nature including retrospective clinical data from birth to the most recent encounter with all data entered in chronological fashion. The goals of this registry are the better understanding of the natural history and treatment outcomes of these patients and to determine/evaluate biochemical and clinical parameters for monitoring and prognosis of tyrosinemia type I.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Biochemical or molecular diagnosis of Tyrosinemia Type I.
- • 2. Examined/followed by one of the participating sites.
- • 3. Parental/guardian permission (informed consent) for participation.
- Exclusion Criteria:
- • 1. Diagnosis of tyrosinemia has been excluded.
- • 2. Not examined/followed by one of the participating sites.
- • 3. Unwilling to provide informed consent for participation.
About Yassin Abdelghaffar Charity Center For Liver Disease And Research
The Yassin Abdelghaffar Charity Center for Liver Disease and Research is a dedicated clinical trial sponsor focused on advancing the understanding and treatment of liver diseases. Committed to innovative research and compassionate care, the center conducts rigorous clinical trials aimed at improving patient outcomes and enhancing therapeutic options. With a multidisciplinary team of experts, the center fosters collaboration and strives to translate research findings into effective clinical practices, ultimately benefiting patients suffering from liver conditions. Through its charitable mission, the center also seeks to raise awareness and support for liver health within the community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nasr City, Cairo, Egypt
Patients applied
Trial Officials
Tawhida Y Abdelghaffar, MD
Principal Investigator
Yassin Abdelghaffar Charity Center for Liver Disease and Research
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials